Patients' experience of accessing hepatitis C treatment through the Myanmar national hepatitis C treatment program: a qualitative evaluation
Abstract Background Globally, 56.8 million people are living with hepatitis C and over three-quarters of those reside in low and middle-income countries (LMICs). Barriers and enablers to hepatitis C care among people who inject drugs in high-income countries are well documented. However, there is sc...
Saved in:
Main Authors: | Bridget Draper (Author), Win Lei Yee (Author), Anna Bowring (Author), Win Naing (Author), Khin Pyone Kyi (Author), Hla Htay (Author), Jessica Howell (Author), Margaret Hellard (Author), Alisa Pedrana (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2024-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Reducing liver disease-related deaths in the Asia-Pacific: the important role of decentralised and non-specialist led hepatitis C treatment for cirrhotic patients
by: Bridget Draper, et al.
Published: (2022) -
Hepatitis C elimination in Myanmar: Modelling the impact, cost, cost-effectiveness and economic benefits
by: Nick Scott, et al.
Published: (2021) -
Patients' access to and acceptance of community-based hepatitis C testing and treatment in Myanmar: A mixed-method study.
by: Win Lei Yee, et al.
Published: (2023) -
Access to needles and syringes and methadone maintenance therapy among people who inject drugs in Yangon, Myanmar: a qualitative study
by: Win Lei Yee, et al.
Published: (2022) -
Heterogeneity in hepatitis C treatment prescribing and uptake in Australia: a geospatial analysis of a year of unrestricted treatment access
by: Nick Scott, et al.
Published: (2018)